Symrise AG Unsponsored ADR (OTCMKTS:SYIEY - Get Free Report) was the target of a significant decline in short interest in the month of September. As of September 15th, there was short interest totaling 27,800 shares, a decline of 41.0% from the August 31st total of 47,100 shares. Based on an average daily volume of 509,800 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 509,800 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analyst Weigh In
Separately, Baader Bank upgraded Symrise to a "buy" rating in a research report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Buy".
Get Our Latest Report on Symrise
Symrise Trading Up 0.9%
OTCMKTS:SYIEY traded up $0.20 on Friday, hitting $22.04. The stock had a trading volume of 93,787 shares, compared to its average volume of 243,505. The company has a quick ratio of 0.83, a current ratio of 1.49 and a debt-to-equity ratio of 0.34. The business's fifty day moving average is $23.20 and its 200 day moving average is $25.99. Symrise has a 52 week low of $21.03 and a 52 week high of $33.31.
Symrise Company Profile
(
Get Free Report)
Symrise AG supplies fragrances, flavorings, cosmetic active ingredients and raw materials, and functional ingredients in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. It operates through two segments, Taste, Nutrition & Health; and Scent & Care. The Taste, Nutrition & Health segment provides functional ingredients and product solutions used in the production of food and beverages; savory flavors; natural and sustainable ingredients for food and beverage manufacturers, baby food, and dietary supplements; product solutions and services for pet food manufacturers; sustainable ingredients and services for fish feed manufacturers to develop solutions for fish and shrimp farms; and probiotics for food supplements and functional foods.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Symrise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Symrise wasn't on the list.
While Symrise currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.